Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome: a Multicentre, Randomized, Double-blind, Parallel-group, Placebo-controlled Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06681012

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:04.259332+00:00

Published At

2026-04-03T00:00:00+00:00

Record Updated At

2026-04-03

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Irritable Bowel Syndrome (IBS)", "Irritable Bowel Syndrome of Diarrhea Type (IBS-D)"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-04-03"

protocolSection.identificationModule.nctId

"NCT06681012"

protocolSection.identificationModule.officialTitle

"Gelsectan\u00ae in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome: a Multicentre, Randomized, Double-blind, Parallel-group, Placebo-controlled Study"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Irritable Bowel Syndrome (IBS) (protocolSection.conditionsModule.conditions)
• Irritable Bowel Syndrome of Diarrhea Type (IBS-D) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.